OQS
AGL icon

Occudo Quantitative Strategies’s Agilon Health AGL Stock Holding History

Occudo Quantitative Strategies’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,980
Closed -$1.18M – 983
2023
Q1 		$1.18M Buy
+1,980
New +$1.11M 0.11% 285
2022
Q4 		– Sell
-1,847
Closed -$1.08M – 928
2022
Q3 		$1.08M Buy
+1,847
New +$1.11M 0.08% 373

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Occudo Quantitative Strategies's AGL Position: Q2 2023 in Review

Occudo Quantitative Strategies sold out of Agilon Health (AGL) in Q2 2023, closing a stake of 1,980 shares — an estimated $1.18M sold.

Occudo Quantitative Strategies first reported a position in AGL in Q3 2022 and held it in 2 quarters. The position peaked at $1.18M in Q1 2023. 185 funds tracked by Wall St. Rank hold AGL as of Q2 2023.

  • Occudo Quantitative Strategies reported no remaining Agilon Health position as of Q2 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,980 Agilon Health shares in Q2 2023, an estimated $1.18M.
  • Occudo Quantitative Strategies first reported a position in Agilon Health in Q3 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Agilon Health position peaked at $1.18M in Q1 2023.
  • 185 funds tracked by Wall St. Rank held Agilon Health as of Q2 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.